Gene · 466
Papers2,331
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,331
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Minimal Infiltrative Disease Identification in Cryopreserved Ovarian Tissue of Girls with Cancer for Future Use: A Systematic Review. | Cancers (Basel) | 2023 | 37686475 | PubTator, text mining | PubMed |
| Mitochondrial Factors in the Cell Nucleus. | Int J Mol Sci | 2023 | 37686461 | PubTator, text mining | PubMed |
| MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. | NPJ Precis Oncol | 2023 | 37679505 | PubTator, text mining | PubMed |
| Fission yeast Cdc14-like phosphatase Flp1/Clp1 modulates the transcriptional response to oxidative stress. | Sci Rep | 2023 | 37674027 | PubTator, text mining | PubMed |
| Characterization of host substrates of SARS-CoV-2 main protease. | Front Microbiol | 2023 | 37670988 | PubTator, text mining | PubMed |
| DNA methylation patterns in CD4+ T-cells separate psoriasis patients from healthy controls, and skin psoriasis from psoriatic arthritis. | Front Immunol | 2023 | 37662940 | PubTator, text mining | PubMed |
| Systematic investigation of the homology sequences around the human fusion gene breakpoints in pan-cancer - bioinformatics study for a potential link to MMEJ. | Brief Bioinform | 2023 | 37635381 | PubTator, text mining | PubMed |
| Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review). | Mol Clin Oncol | 2023 | 37614371 | PubTator, text mining | PubMed |
| Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer. | Int J Mol Sci | 2023 | 37569299 | PubTator, text mining | PubMed |
| Unraveling the Complex Web of Mechanistic Regulation of Versatile NEDD4 Family by Non-Coding RNAs in Carcinogenesis and Metastasis: From Cell Culture Studies to Animal Models. | Cancers (Basel) | 2023 | 37568787 | PubTator, text mining | PubMed |
| Hyalinising clear cell carcinoma with a novel fusion gene: Insights into the diagnosis. | Cytopathology | 2023 | 37555501 | PubTator, text mining | PubMed |
| Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review. | Diagn Pathol | 2023 | 37553667 | PubTator, text mining | PubMed |
| [Malignant gastrointestinal neuroectodermal tumor: a clinicopathological analysis of three cases]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 37527982 | PubTator, text mining | PubMed |
| Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks. | Biochem Biophys Res Commun | 2023 | 37523894 | PubTator, text mining | PubMed |
| SARS-CoV-2 uses CD4 to infect T helper lymphocytes. | Elife | 2023 | 37523305 | PubTator, text mining | PubMed |
| In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19. | Hum Gene (Amst) | 2023 | 37520333 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures. | Int J Mol Sci | 2023 | 37511137 | PubTator, text mining | PubMed |
| Soft Tissue Sarcoma Mimicking Melanoma: A Systematic Review. | Cancers (Basel) | 2023 | 37509250 | PubTator, text mining | PubMed |
| Identification of mammalian transcription factors that bind to inaccessible chromatin. | Nucleic Acids Res | 2023 | 37486787 | PubTator, text mining | PubMed |
| Genome Doubling Shapes High-Grade Transformation and Novel EWSR1::LARP4 Fusion Shows SOX10 Immunostaining in Hyalinizing Clear Cell Carcinoma of Salivary Gland. | Lab Invest | 2023 | 37479138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/466/papers?page=9